Clinical Trial Update: Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update noting the completion of the INOSTA study evaluating inhaled nitric oxide for acute chest syndrome in sickle cell disease across Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease, Acute Chest Syndrome | Phase 2, Phase 3 | Status: COMPLETED